Latest News

May 30, 2017

Innovation and FDA’s Regulatory Frameworks: Catalyst Co-Authors Explore How the Coming Data Shift Will Impact Medical Product Regulation in Therapeutic Innovation & Regulatory Science Article

May 30, 2017 / 0 Comments 0 Comments
Given rapid advances in technology and our understanding of disease, the future will bring a shift in how the health care system thinks about and uses data, Michael Doherty, Foundation… read more →
April 24, 2017

Former FDA Associate Commissioner Jill Hartzler Warner Joins Catalyst Team, Expanding the Firm’s Expertise in Regenerative Medicine, Rare Disease Drug Development and Combination Product Regulation

April 24, 2017 / 0 Comments 0 Comments
Press release Washington, DC – Catalyst Healthcare Consulting is pleased to announce that Jill Hartzler Warner, JD, has joined the firm as Vice President, Regulatory Policy. She will advise clients… read more →
April 20, 2017

Trump’s Deregulatory Agenda: What It Could Mean For Biopharma & Medtech Companies

April 20, 2017 / 0 Comments 0 Comments
Pharmaceutical Online-  What do President Trump’s deregulatory executive orders mean for the industry? In this article in Pharmaceutical Online, Catalyst’s Nancy Bradish Myers and Anne Petruska McNickle explore Trump’s “2-for-1”… read more →

View News Archive

Latest Events

June 12, 2017

FDA User Fees, Drug Competition and Drug Pricing: Catalyst to Present on Regulatory and Legislative Vehicles for Change

June 12, 2017 / 0 Comments 0 Comments
On June 13, Catalyst President Nancy Bradish Myers will present on PDUFA and other user fee agreements, and their impact on drug competition. Ms. Myers will be a featured speaker… read more →
March 1, 2017

DIA Annual Meeting 2017: CRISPR, Disruptive Innovation Panels to be Moderated by Catalyst

March 1, 2017 / 0 Comments 0 Comments
Catalyst will moderate two panel discussions exploring various types of disruptive innovation during the DIA’s 2017 Annual Meeting. On June 20, Catalyst President Nancy Bradish Myers will moderate a panel… read more →
February 15, 2017

RxAdherence Annual Meeting: Catalyst to Present on FDA and the Trump Administration

February 15, 2017 / 0 Comments 0 Comments
During the RxAdherence “Strategies to Improve Outcomes” annual meeting, Catalyst President Nancy Bradish Myers will give a presentation on FDA the Trump Administration. Ms. Myers’ presentation at the 2017 annual… read more →

View Events Archive

Back to Top
UA-64850428-1